bullish
Japan Pharmaceuticals: The Week that Was…
104 Views13 Apr 2018 17:33
Takeda Pharmaceutical Co Ltd (4502 JP) @ ¥ 4,911/ share (down 24% YTD) implies ~17x (~30% discount to industry average) our FY19e core EPS of ¥...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
- Japan Pharmaceuticals: The Week that Was…13 Apr 2018
- Ono’s Stock Price Decline on Merck’s KN-042 Success12 Apr 2018
- Japan Pharma: Upcoming Catalysts & Event Driven Trading Ideas06 Apr 2018
- Takeda + Shire - Highly Accretive Merger Considering Takeda’s Core Earnings02 Apr 2018
x